20
Participants
Start Date
July 9, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2040
CD4CAR
CD4CAR cells transduced with a lentiviral vector to express the single-chain variable fragment (scFv) nucleotide sequence of the anti-CD4 molecule derived from humanized monoclonal ibalizumab and the intracellular domains of CD28 and 4-1BB co-activators fused to the CD3ζ T-cell activation signaling domain administered by IV infusions as a single dose
RECRUITING
Albert Einstein Health Network, New York
ACTIVE_NOT_RECRUITING
Stony Brook Cancer Center, Stony Brook
RECRUITING
University of Miami Sylvester Comprehensive Cancer Center, Miami
RECRUITING
Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Collaborators (1)
iCell Gene Therapeutics
INDUSTRY
Huda Salman
OTHER